T. Rowe Price ( TROW ) Stock Sinks As Market Gains: What You Should Know
In the closing of the recent trading day, T. Rowe Price (TROW) stood at $92.15, denoting a -1.54% change from the preceding trading day.
Why AbCellera Biologics Stock Raced Nearly 6% Higher Today
Investors were surely discovering drug discovery company AbCellera Biologics ( NASDAQ: ABCL ) as the trading week kicked off on Monday. On encouraging news in an important North American jurisdiction, those folks bid the biotech's stock up by almost 6% on the day.
Why Genmab Stock Smashed It on Monday
On a generally upbeat Monday for the stock market, investors weren't only buying into U.S. companies. Quite a few of them also piled into the American Depositary Receipts ( ADRs ) of Danish biotech Genmab ( NASDAQ: GMAB ) , on the back of encouraging news from the laboratory.
Accenture: A Strong Player in Consulting with Room for Growth
Explore the exciting world of Accenture ( NYSE: ACN ) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of April 28, 2025.
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 ( GLOBE NEWSWIRE ) -- Ascentage Pharma ( NASDAQ: AAPG. HKEX: 6855 ) , a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase Ib/II study of the ...
DeFi Development Corp. Delivers Record Month with Key Integrations, Treasury Growth, and Institutional Partnerships
BOCA RATON, FL, June 02, 2025 ( GLOBE NEWSWIRE ) -- DeFi Development Corp. ( Nasdaq: DFDV ) ( the "Company" or "DeFi Dev Corp." ) , the first US public company with a treasury strategy built to accumulate and compound Solana ( "SOL" ) , today announced a record-setting May 2025 highlighted by ...
Crypto broker FalconX acquires majority stake in Monarq - Report
FalconX has made other moves in 2025, acquiring derivatives startup Arbelos Markets and partnering with Standard Chartered.
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 ( GLOBE NEWSWIRE ) -- Ascentage Pharma ( NASDAQ: AAPG. HKEX: 6855 ) , a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical data from its Phase II study of the ...